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Recent investigations have shown the Egyptian fruit bat (Rousettus aegyptiacus) to be a natural reservoir
for marburgviruses. To better understand the life cycle of these viruses in the natural host, a new reverse
genetics system was developed for the reliable rescue of a Marburg virus (MARV) originally isolated
directly from a R. aegyptiacus bat (371Bat). To develop this system, the exact terminal sequences were
ﬁrst determined by 5′ and 3′ RACE, followed by the cloning of viral proteins NP, VP35, VP30 and L into
expression plasmids. Novel conditions were then developed to efﬁciently replicate virus mini-genomes
followed by the construction of full-length genomic clones from which recombinant wild type and GFP-
containing MARVs were rescued. Surprisingly, when these recombinant MARVs were propagated in
primary human macrophages, a dramatic difference was found in their ability to grow and to elicit anti-
viral cytokine responses.
Published by Elsevier Inc.Introduction
Marburgviruses (family Filoviridae) are the causative agents of
large hemorrhagic fever outbreaks in sub-Saharan Africa with high
case fatality. The genus Marburgvirus contains a single virus
species that has two virus members, Marburg virus (MARV) and
Ravn virus (RAVV). As members of the Order Mononegavirales,
marburgviruses contain single-stranded RNA genomes of negative
polarity and are approximately 19 kilobases in length. Marburg-
virus genomes contain seven monocistronic genes, each consisting
of transcription start/termination sequences, a 3′ and 5′ untrans-
lated region, and a single open reading frame (ORF) (Sanchez et al.,
2007). Relative to most other members of the Mononegavirales,
marburgvirus intergenic regions are unusual in that they consist of
short, variable nucleotide stretches, or contain highly conserved
overlaps between the upstream gene transcription termination
sequence and the corresponding downstream gene transcription
start sequence (Feldmann et al., 1992).Inc.
ours and do not necessarily
l and Prevention.For marburgviruses, the events that lead to virus spillover to
humans are becoming better understood as mounting evidence
shows that the Egyptian fruit bat (Rousettus aegyptiacus) is a
natural reservoir (Amman et al., 2012; Swanepoel et al., 2007;
Towner et al., 2009, 2007). This determination was based on
epidemiologic linkage of many human outbreaks to large R.
aegyptiacus populations and the repeated isolation of highly
diverse marburgvirus lineages from bats caught at the site of
known or suspected spillover events. Consistent with expectations
for a virus that has co-evolved with its reservoir host, marburg-
viruses appear to cause little disease in R. aegyptiacus (Paweska
et al., 2012; Towner et al., 2009), which contrasts the severe, often
fatal disease found in human and non-human primates (NHPs).
Previous studies of MARV replication in experimentally infected R.
aegyptiacus are difﬁcult to interpret because the virus inoculum had
been passaged 38 times in an interferon negative primate cell line
(Vero cells) prior to its use (Paweska et al., 2012). Such extended
replication in the absence of natural selective pressures will likely
result in the accumulation of mutations that could reduce virus
ﬁtness if experimentally re-introduced into R. aegyptiacus. Therefore,
as a ﬁrst step to generate authentic tools for dissecting the viral
molecular genetic determinants for future experimental infection
studies of R. aegyptiacus, we developed an efﬁcient and reproducible
reverse genetics system to rescue a recombinant MARV possessing
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371Bat2007, isolate 811277) originally obtained directly from a
MARV-infected bat captured at Kitaka Cave in western Uganda
(Towner et al., 2009). Both ‘wild type’ and GFP-containing viruses
were rescued.
The sequence of 371Bat MARV differs from the closest human
MARV isolate, 01Uga07, by 120 nucleotides across the genome.
Presumably, if R. aegyptiacus are indeed the natural virus source
from which humans become infected, then a low passaged
(passage 2) bat-derived virus should likely replicate as well as a
similarly passaged human-derived isolate when tested in human
immunocompetent cells. To test this hypothesis, the growth of
wild type (wt) and recombinant bat-derived MARVs were com-
pared side-by-side with a similarly low passage human isolate in
primary human macrophages. As predicted, the wild type bat- and
human-derived viruses replicated to similar levels. However, the
recombinant bat virus containing the GFP gene insertion in the
virus genome was found to have diminished replication in macro-
phages and effected profound changes in the RNA expression
levels of human host cell cytokine and chemokine genes. These
data suggest that perturbations in natural virus transcriptional
regulation may cause dramatic changes in the virus′s ability to
carry out immune modulatory processes.Results and discussion
Whole genome sequencing of the MARV isolate from 371Bat
has been previously performed (Towner et al., 2009). The sequence
(GenBank FJ750958) is o1% divergent from a virus isolated from
an infected miner working in the same cave (01Uga2007, GenBank
FJ750957), 7–8% divergent from some other well-characterized
MARV lineage isolates (including the Musoke strain), and 421%
divergent from RAVN viruses (Fig. 1A). All sequences analyzed
follow the basic ﬁloviral genome organization of seven genes with
intergenic regions and untranslated termini at both ends (Fig. 1B).
Prior to attempting a cloning strategy, the terminal 5′ and 3′ UTRs
of 371Bat virus were experimentally determined since these
terminal 20 nucleotides were initially dictated by ampliﬁcation
primers during the original sequencing. Using rapid ampliﬁcation
of cDNA ends (RACE) it was found that two nucleotides near the 3′
end of the anti-genome differed from the original sequence.
The ﬁrst change consisted of an ‘A’ residue at position 19105 of
the original sequence that was clearly a ‘T’ residue when experi-
mentally determined (Fig. 1C, left box), while the second change
was an incorrect insertion of an ‘A’ residue at position 19114 in the
original sequence (Fig. 1C, right box) indicating that the total
genome length is in fact 19113 nucleotides and not 19114 nucleo-
tides. The 5′ terminal nucleotide of the genomic sense RNA is now
a ‘C’. We suspect that both differences were likely introduced by
the primers used for generation of RT-PCR products from which
the original sequence was determined.
Using the corrected sequence for the 371Bat virus, both mini-
and full-length genome ampliﬁcation systems were constructed.
For the mini-genome system, RT-PCR was used to amplify the
ORFs of 371Bat nucleoprotein (NP), viral protein (VP) 35, VP30, and
polymerase (L), all of which were cloned using standard techni-
ques into a pol II expression plasmid. As a negative control, an
additional support plasmid was constructed that generated an
inactive polymerase by substituting Ala residues for the highly
conserved GDN motif found in the polymerase (Fig. 1D). For the
GFP-containing mini-genome, the GFP sequence was cloned into a
standard T7 transcription plasmid ﬂanked by the 371Bat 3′ and 5′
UTRs in viral (genome) sense. BSR-T7/5 cells (Buchholz et al., 1999)
stably expressing the T7 RNA polymerase were transfected with
supporting and mini-genome plasmids, and monitored for GFPexpression as an indicator of RNA transcription and replication.
Cells expressed GFP as early as two days post-transfection, and
reached maximum expression four days post-transfection
(Fig. 2A). Co-transfection of NP, L, and VP35 supporting plasmids
was sufﬁcient to observe mini-genome replication (Fig. 2A), as has
been previously reported (Muhlberger et al., 1998, 1999). Interest-
ingly, addition of VP30 supporting plasmid increased the number
of cells able to replicate the GFP mini-genome. As expected, the
use of supporting polymerase plasmid containing the mutated
GDN motif completely ablated GFP expression (Fig. 2A).
Although GFP expression was clearly detectable in BSR-T7/5
cells, the percentage of cells replicating mini-genomes was less
than 30%. Additionally, the kinetics of this system was relatively
slow (strongest GFP signal at 4d post-transfection), making it less
than ideal for shorter-term experiments. To circumvent these
problems, each support protein ORF was codon-optimized for
rodent cell expression and cloned into the pol II expression vector.
Co-transfection of these new plasmids (denoted by a “co” in Fig. 2)
with the GFP mini-genome led to rapid GFP expression, with green
cells visible by 24 h post-transfection (data not shown). By 48 h
post-transfection, most BSR-T7/5 cells receiving all codon-
optimized support plasmids expressed GFP (Fig. 2B). The largest
single increase in GFP expression was brought about by the
addition of the codon-optimized polymerase, although addition
of all codon-optimized plasmids resulted in the greatest total
number of cells expressing GFP and highest intensity of signal.
Interestingly, codon-optimized NP or VP35 plasmids used indivi-
dually with non-optimized plasmids resulted in the poorest levels
of GFP expression, even worse than the complete non-codon-
optimized system, suggesting that the overexpression of NP or
VP35 relative to the other replication proteins may somehow
negatively affect replication. In contrast, the individual utilization
of codon-optimized VP30 plasmid with non-optimized NP, VP35
and L resulted in similar GFP expression as the all non-codon-
optimized system, conﬁrming that VP30 expression does not have
a dramatic positive or negative affect on mini-genome replication
(Fig. 2B).
After conditions were determined for optimal mini-genome
expression, a full-length recombinant clone based on the 371Bat
virus genome sequence was constructed. This plasmid was initially
built in viral complementary (antigenomic) sense (Fig. 3) as
previously published data suggested that this orientation was
the most efﬁcient for viral rescue in Marburg and Ebola virus
systems (Enterlein et al., 2006; Neumann et al., 2002; Volchkov
et al., 2001). Three additional full-length 371Bat clones were built,
each with the GFP gene inserted in one of the intergenic regions
between NP-VP35, GP-VP40, or trailing the polymerase in the 3′
UTR. All four full-length clones were also constructed in the viral
(genomic) sense. Initial attempts at rescue in BSR-T7/5 cells using
all codon-optimized support plasmids were met with very limited
success. Brieﬂy, clariﬁed supernatants or cell lysates from BSR-T7/5
collected at 3–7 days post-transfection were used to infect VeroE6
cells. Out of more than 100 separate attempts, only once was a
recombinant virus rescued, and this virus contained GFP inserted
in between NP and VP35 (data not shown).
During the course of these rescue experiments, it was noticed
that the BSR-T7/5 cells would quickly become 100% conﬂuent and
undergo cell death despite carrying out the initial transfections
when cells were o50% conﬂuent. We therefore hypothesized
that the rapid cell growth was resulting in the death of success-
fully transfected cells before detectable virus was produced.
To overcome this problem, we performed similar transfections
in the parental BHK-21 cell line which grow at a slower rate.
Because BHK-21 cells do not constitutively express T7 RNA
polymerase, the pC-T7 plasmid was additionally added to the
transfection mix.
Fig. 1. (A) Sequence similarity of Marburg virus 371Bat isolate to other known bat (B) and human (H) isolates. Sequences obtained from Genbank (FJ750958, FJ750957,
DQ217792, JN408064, JX458853, DQ447649, JX458857, FJ750953) were aligned and the nucleotide similarity was determined using Mega5 (Tamura et al., 2011). (B) Basic
organization of the marburgvirus genome. The seven ORFs are depicted in the viral complementary sense (5′ to 3′). (C) 5′ and 3′ terminal sequences currently reported for
371Bat isolate (top, Genbank ♯FJ750958) compared to sequencing results of 371Bat isolate obtained by RACE (bottom). Chromatograms are displayed below sequences, and
blue boxes indicate where RACE sequence diverges from reported sequence. (D) Schematic of GFP mini-genome plasmid with 371Bat 5′ and 3′ UTRs (black line), and viral
protein expression plasmids used in both mini- and full-length genome experiments (dashed line indicates pCAGGS plasmid sequence).
C.G. Albariño et al. / Virology 446 (2013) 230–237232The rescue attempt in BHK-21 cells was successful, and the non-
GFP recombinant ‘wild type’ virus (rMbg) was rescued for the ﬁrst
time in 4/22 wells of a single experiment (20% efﬁciency, Fig. 3A).
Moreover, the efﬁciency of virus rescue from rMbg-FL/GFP2849 was
greatly increased in these cells, as evidenced by virus rescue in 21/24
wells of a single experiment (90% efﬁciency, Fig. 3B). After perform-
ing a total of 12 rescue attempts in numerous independent experi-
ments the results have remained remarkably consistent, with rescue of
non-GFP viruses occurring with 20–30% efﬁciency and GFP-containing
viruses (rMbg/GFP) at 70–95% efﬁciency. In spite of the initial success,
no virus rescue was achieved when using full-length genomic-sense
clones or antigenomic clones with GFP inserted between GP and VP40,
or after the L gene 3′ UTR.
Once rescued, both viruses grew to similar titers in VeroE6
cells, with almost 100% of VeroE6 cells positive by IFA and/or GFP
expression four days post-infection. Interestingly, rMbg/GFP seems
to grow slightly faster in VeroE6 cell culture during the ﬁrst three
days of infection than either rMbg or wild type 371Bat virus
(Fig. 3C). The faster growth phenotype observed with rMbg/GFP
virus in VeroE6 cells may partially explain why this virus is
rescued with greater efﬁciency than the rMbg virus.During early stages of marburgvirus infections of humans and
NHPs, the primary sites of virus replication are thought to be
monocytes, macrophages, and dendritic cells (Fritz et al., 2008;
Geisbert and Jaax, 1998; Hensley et al., 2011). If bats are indeed the
initial source of marburgviruses leading to human outbreaks, we
reasoned that viruses derived directly from bats with little
opportunity to accumulate cell culture adaptations should efﬁ-
ciently infect primary human macrophages. To test this hypoth-
esis, we infected human CD14+ macrophages with a minimally
passaged human isolate (01Uga07), wild type 371Bat virus, and
both GFP and non-GFP recombinant 371Bat viruses, and compared
viral growth. As expected, rMbg 371Bat virus and the 01Uga07
human isolate grew to similar levels, but interestingly rMbg/GFP
virus grew to titers 1–2 logs less (Fig. 4B). This result was
unexpected because rMbg and rMbg/GFP viruses grew to similar
levels in VeroE6 cells (Fig. 3C), indicating that the insertion of an
extra-cistronic gene between NP and VP35 did not affect the virus
replication. To further explore the growth defect of the rMbg/GFP
virus in human macrophages, mRNA levels of the genes up- and
down-stream of the GFP insertion were measured by qRT-PCR.
The infected cell data indicate that compared to rMbg virus, the
Fig. 2. Replication of 371Bat-based GFP mini-genome. GFP expression was assessed as an indicator of mini-genome replication in BSR-T7/5 cells using (A) wild type and
(B) codon-optimized viral protein support plasmids. Images were taken either four days (A) or two days (B) post-transfection.
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the downstream VP35 and VP40 genes relative to the upstream NP
mRNA (data not shown). This observation is consistent with
the established paradigm for transcriptional polarity observed in
single-strand negative sense RNA viruses and may indicate that, at
least in macrophages, the GFP gene insertion results in lower
levels of downstream replication proteins necessary for virus
transcription and genome replication. An alternative explanation
for attenuated virus growth in macrophages is that the diminished
levels of VP35, VP40, and supposedly VP24 affect their ability to
carry out the innate immune-modulatory functions ascribed to
them (Ramanan et al., 2011; Valmas et al., 2010). Therefore, in
order to test the latter hypothesis, we measured the expression of
selected cytokine and chemokine genes in human macrophages
mock-infected or infected with 01Uga07, wt 371Bat, rMbg and
rMbg/GFP viruses. In support of this hypothesis, rMbg/GFP virus
elicited increased anti-viral inﬂammatory mediators over levels
observed when macrophages were infected with non-GFP MARVs
(Fig. 4C). These differences were most striking with CXCL10/IP-10
and CCL5/RANTES, with more modest differences seen for CCL4/
MIP-1β and tumor necrosis factor (TNF). Several other cytokines
remained unchanged independent of the type of MARV used for
infection, including IL6, IL8, IL1RN, IL1β, and IL12β (Fig. 4C and data
not shown).
To determine if the extra-cistronic gene insertion between NP
and VP35 causes similar downstream mRNA reductions in other
ﬁloviruses, a recombinant Ebola virus (rEbov) also containing GFP
inserted between NP and VP35 (Towner et al., 2005) was tested
using the same assay. As expected, only rEbov with GFP inserted in
the NP-VP35 intergenic region elicited detectable cytokine/che-
mokine responses over the equivalent non-GFP virus (data not
shown). The similarity of responses elicited in human macro-
phages by both MARVs and EBOVs containing an extra-cistronic
gene suggests that important immune-modulatory functions canbe perturbed when the natural order of transcription is altered by
the insertion of an additional transcription unit. Our results are
consistent with previous reports describing the low pathogenicity
of GFP-containing EBOVs in infected mice and NHPs (Ebihara et al.,
2007).Conclusions
We report here a reverse genetics system that reliably gener-
ates an infectious MARV whose sequence is identical to a virus
originally isolated directly from a R. aegyptiacus bat (371Bat). We
also report the successful rescue of this bat-derived virus contain-
ing an insertion of the GFP reporter gene, as well as a robust
GFP-based mini-genome reporter system. Although virus rescue
systems have been previously developed for MARV (Musoke), such
viruses were originally isolated from human clinical samples
followed by multiple rounds of virus passage in cell culture
(Ebihara et al., 2005; Hoenen et al., 2011). These virus passage
histories may have allowed for the accumulation of adaptive
mutations detrimental for virus replication in its cognate reservoir
host. The full-length genomes reported here have identical
sequence to the second VeroE6 passage of the 371Bat isolate,
and as such are more authentic tools for examining how MARVs
replicate and survive in their zoonotic reservoir.
MARVs containing both GFP and wild type full-length recom-
binant genomes are rescued with high efﬁciency and reproduci-
bility. We hypothesize that the use of codon-optimized support
plasmids leads to more rapid viral protein production and, when
used in a slower-growing but transfectable cell type (BHK-21), the
prolonged time-to-death allows for greater numbers of complete
virions to be produced for eventual rescue. Based on data from
mini-genome studies, it has been previously suggested that inser-
tion of GFP in the NP-VP35 intergenic region may alter the ratio
Fig. 3. Rescue and characterization of recombinant 371Bat MARV using full-length viral complementary genomes. (A) Wild type recombinant MARV (rMbg) was rescued in
BHK-21 cells using the full-length genome depicted, T7 polymerase plasmid, and codon-optimized viral support protein plasmids NP, VP35, VP30, and L. Efﬁciency of rescue
in a single experiment is shown as wells positive/total wells, and average titer was assessed by standard TCID50 assay. VeroE6 cells were infected with rMbg virus, ﬁxed
4 days post-infection, and stained for immunoﬂuoresence assay (IFA) using a polyclonal rabbit anti-Marburg antibody followed by anti-rabbit Alexa-Fluor 594.
(B) A recombinant MARV containing the GFP ORF in the intergenic region of NP and VP35 (rMbg/GFP) was rescued under similar conditions as wild type. VeroE6 cells
were infected with rMbg/GFP virus and visualized for GFP expression (left) or subjected to the same immunoﬂuorescence assay as in (A) (middle, merged images at right).
(C) Wild type 371Bat (Mbg (wt)), rMbg, and rMbg/GFP viruses were used to infect VeroE6 cells at an MOI of 0.01 to assess growth kinetics. Adsorption was allowed for 1 h,
after which cells were washed with PBS and given complete growth media. At time points indicated, supernatant was taken and titered by TCID50 assay on VeroE6 cells.
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rescue may not be possible (Muhlberger et al., 1998; Schmidt et al.,
2011). Our results show that reporter genes are well tolerated in
this particular region with no adverse effects on infectious virus
rescue or growth. However, the insertion of GFP gene between GP-
VP40 genes, or after the L gene, seems to be highly detrimental in
our system.
Further, and importantly, our data also suggests that such
insertions may result in delayed or decreased transcription of viral
genes proposed to modulate the immune system, which may
explain the higher expression of anti-viral genes and the growth
defect of rMbg/GFP observed in human macrophages. We expectthat wild type and reporter-containing recombinant marburg-
viruses based on bat-derived virus isolates will prove invaluable
for future studies in the natural reservoir and potential spillover
hosts.Materials and methods
Cell culture and biosafety
All work with infectious Marburg virus and attempts to rescue
the virus from cDNA were performed in a biosafety level 4 (BSL-4)
Fig. 4. (A) Infection of human macrophages with wild type or recombinant MARV. CD14+ monocytes were allowed to mature to macrophages for 7 days and infected with
indicated viruses at an MOI of 0.1. IFA was performed as in Fig. 3. (B) Growth kinetics of wild type or recombinant MARV in CD14+ macrophages. Titers were obtained on
VeroE6 cells as in Fig. 3C. (C) Pro-inﬂammatory responses of human macrophages infected with wild type or recombinant marburgviruses. Seven days post-maturation, cells
were infected with the indicated viruses at an MOI of 2 and total RNA was harvested 24 h later. Expression of inﬂammatory-related genes was assessed using a custom
qRT-PCR array, and plotted as fold induction over mock-infected cells.
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BSR-T7/5, BHK21, and VeroE6 cells were propagated in Dulbecco′s
modiﬁed Eagle′s medium (DMEM) supplemented with 5% fetal
bovine serum (FBS) and penicillin-streptomycin as recommended
by the manufacturer (Invitrogen). BSR-T7/5 cells were maintained
under G-418 (1 mg/ml Geneticin; Invitrogen) selection pressure
every other passage.Terminal sequences of viral genome
The genomic sequence of the Marburg 371Bat virus isolate
(Genbank FJ750958) was previously reported (Towner et al.,
2009), but the 5′ and 3′ termini of the RNA corresponded to
primer sequences. Viral RNA from this isolate was therefore used
as the template to determine the terminal sequences and to
generate all cDNA clones. The 5′ and 3′ termini of the virus were
determined by rapid ampliﬁcation of cDNA ends (RACE) using
FirstChoice RLM-RACE kit (Ambion) and previously reported pro-
tocols (Dodd et al., 2011), respectively.Plasmid construction
(A) Mini-genome. Two fragments consisting of 103 and 637 nt
from the 5′ and 3′ antigenome ends, respectively, were ampliﬁed
by RT-PCR using the SuperScript III One-Step RT-PCR system with
Platinum Taq High Fidelity (Invitrogen). These fragments were
cloned into a standard T7 transcription vector (Albarino et al.,
2009), yielding an empty mini-genome cloned in genomic orien-
tation and ﬂanked by the T7 promoter (5′ terminus) and the
hepatitis delta virus ribozyme and T7 polymerase terminator
motifs (3′ terminus). The enhanced GFP ORF (GFP) was inserted
into the empty mini-genome between the RACE-corrected 103 and
637 nt fragments such that GFP expression is driven by the NP
gene transcription start and the L gene transcription termination
sequences. (B) Full-length clones. Three fragments of similar size
spanning the full-length genome of 371Bat Marburg virus were
ampliﬁed by RT-PCR. Each of these fragments was cloned inde-
pendently, sequenced to completion, and used to assemble the
full-length antigenome into the T7 transcription vector (a detailed
cloning strategy is available upon request). The ﬁnal plasmid
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ﬂanked by the T7 RNA polymerase promoter, including an addi-
tional 5′ guanine (G) which is required for efﬁcient initiation of the
T7 RNA polymerase, and followed by hepatitis delta virus ribo-
zyme and T7 polymerase terminator motifs. A spurious nt change
(silent mutation) in the L gene was kept to differentiate the
recombinant virus from the wild type virus. Moreover, the full-
length 371Bat Marburg virus genome was cloned into the same T7
transcription plasmid in viral (genome) sense. (C) GFP-expressing
full-length clones. Three different full-length antigenomic clones
were constructed carrying the enhanced GFP ORF (GFP) inserted at
position 2849, 8718, or 19037. In all these constructs, the GFP ORF
was ﬂanked by 12 and 11nt corresponding to the transcription
start and transcription termination of the NP gene, respectively.
Similarly, three full-length genomic (viral sense) clones containing
identical GFP insertions were cloned into the T7 transcription
plasmid. (D) Support plasmids. The ORFs encoding Marburg NP,
VP35, VP30, and L were ampliﬁed by RT-PCR and cloned into the
pCAGGS expression plasmid (Niwa et al., 1991) using standard
cloning techniques. The T7 RNA polymerase gene was ampliﬁed
from BL21 bacterial cells and cloned into pCAGGS. Synthetic genes
containing codon-optimized NP, VP35, VP30, L, and T7 RNA
polymerase ORFs were obtained from a commercial source (Gen-
Script) and cloned into pCAGGS similarly to the wild type ORFs. On
average, the synthetic genes are 73–76% identical to the wild type
sequences. The resulting plasmids were transformed into XL-10
Gold competent bacterial cells (Stratagene) and puriﬁed using
standard protocols (Mini- or Maxi-Prep kit; Qiagen). Prior to use,
all plasmids were sequenced to completion using standard proto-
cols (BigDye3.1; Applied Biosystems).
Mini-genome expression
BSR-T7/5 cells seeded to approximately 75% conﬂuency in 12-
well plates were transfected with 1.5 μg of Marburg mini-genome
plasmid, 0.5 μg pC-L, 0.5 μg pC-NP, 0.05 μg pC-VP35, 0.05 μg pC-
VP30, and 8 μl LT1 transfection reagent following the manufac-
turer′s protocol (Mirus Biotech). The four support plasmids were
necessary for a single cell to most efﬁciently replicate and
transcribe the GFP mini-genome. GFP expression was determined
by direct UV microscopy on live cells.
Rescue of infectious viruses
Viral rescue was attempted in BSRT7/5 cells constitutively
expressing the T7 RNA polymerase, and in BHK21 cells that
required the addition of a ﬁfth support plasmid, pC-T7, to drive
the transcription of the full-length genome. Brieﬂy, a subconﬂuent
(60–70%) cell monolayer growing in 12-well plates were trans-
fected with 1.5 μg pMbg, 0.5 μg pC-L, 0.5 μg pC-NP, 0.05 μg pC-
VP35, 0.05 μg pC-VP30, 0.5 μg of pC-T7 (for BHK21 only), and 10 μl
LT1 transfection reagent (Mirus Biotech). Supernatants from the
transfected cells were harvested four days post-transfection and
clariﬁed by low-speed centrifugation. All rescued viruses were
propagated after a 1:5 dilution in DMEM by infecting (80%)
conﬂuent monolayers of VeroE6 cells seeded in T25 ﬂasks. Clar-
iﬁed virus supernatants were then diluted and passed once more
to generate a working stock of virus for subsequent experiments.
Altogether, the passage history of all viruses used in these studies
was one passage in BSR-T7/5 or BHK21 cells and two passages in
VeroE6 cells. After the second passage, virus supernatants were
inactivated with Tripure (Roche) and RNA extracted using RNeasy
kits (Qiagen). The exact molecular identity of each recombinant
virus was conﬁrmed by full-genome sequencing following the
manufacturer′s protocols (BigDye3.1; Applied Biosystems).Virus titration and growth curves
All viruses were titrated using a standard 50% tissue culture
infective dose (TCID50) protocol in VeroE6 cells. Growth curves
were obtained in VeroE6 cells seeded in T25 ﬂasks that were
infected at a multiplicity of infection (MOI) of 0.01 with rMbg,
rMbg/GFP, or wild type Mbg 371Bat. After a 1 h adsorption, the
inoculum was removed, monolayers were washed three times
with PBS, and DMEM containing 2% FBS was added to replenish
media. The ﬁrst sample was taken immediately to represent the
t¼0, and subsequent samples were taken from 1 to 7 days post-
infection and stored at 70 1C for subsequent titration by TCID50
assay. For visualization of infected cells, monolayers were ﬁxed (4%
formaldehyde in PBS) at four days post-infection and subsequently
labeled with a rabbit anti-Marburg polyclonal antibody and anti-
rabbit Alexaﬂuor 498 or 594 nm secondary antibodies (Molecular
Probes).
Infection of human macrophages
Peripheral blood mononuclear cells were obtained from healthy
human donors, and CD14+ cells were puriﬁed using magnetically
coupled CD14 antibodies (Miltenyi Biotech) as described previously
(McElroy and Nichol, 2012). CD14+ cells were grown in 24 well
plates in complete media (RPMI with 5% FBS, 100 U/ml of penicillin,
100 μg/ml of streptomycin, and 2 mM L-glutamine) for 7 days to
mature to macrophages. To determine the infectivity of wild type
and recombinant MARV on CD14+ cells, matured human macro-
phages were infected with either 01Uga07, 371Bat, rMbg or rMbg/
GFP at an MOI of 0.1. Supernatants were collected over ﬁve days and
titers were obtained on VeroE6 cells using standard TCID50 assay.
To determine the cytokine response of CD14+ cells, matured
human macrophages were infected in duplicate at an MOI of
2 with the viruses indicated above. After 1 h adsorption, the
inoculum was removed, cells were washed and the media was
replenished. At 24 h post-infection, supernatants were collected
and cells were lysed for RNA puriﬁcation.
To standardize extracted RNA, the housekeeping gene GAPDH
was measured by qRT-PCR using TaqMans GAPDH Control
Reagents (human) following the manufacturer′s protocol (Applied
Biosystems). A customized qRT-PCR array (SABiosciences) was
designed to measure the gene expression of 12 inﬂammatory-
related genes (IL1RN, IL1β, IL8, IL6, IL12β, IFNA1, TNF, CCL2, CCL5,
CCL4, CCL3, and CXCL10) using SuperScripts III Platinums SYBRs
Green One-Step qRT-PCR Kit and following the manufacturer′s
protocols (Invitrogen). Data was calculated from two independent
experiments, with mean and standard error of the mean (SEM)
calculated from duplicate wells, and plotted as fold induction over
mock-infected cells.Acknowledgments
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